Novel insights into the molecular mechanisms of HLA class I abnormalities
- 27 November 2011
- journal article
- review article
- Published by Springer Nature in Cancer Immunology, Immunotherapy
- Vol. 61 (2) , 249-254
Abstract
Alterations in the MHC class I surface antigens represent one mechanism of tumor cells to escape from natural or immunotherapy-induced antitumor immune responses. In order to restore MHC class I expression, knowledge about the underlying molecular mechanisms of MHC class I defects in different tumor types is required. In most cases, abnormalities of MHC class I expression are reversible by cytokines suggesting a deregulation rather than structural abnormalities of members of the antigen-processing and presentation machinery (APM). The impaired expression of APM components could be controlled at the epigenetic, transcriptional and/or posttranscriptional level. Furthermore, a direct link between altered transcription factor binding, interferon signal transduction and MHC class I APM component expression has been shown, which might be further associated with cell cycle progression. This information will not only give novel insights into the (patho) physiology of the antigen-processing and presenting pathway, but will help in the future to design effective T cell-based immunotherapies.Keywords
This publication has 44 references indexed in Scilit:
- Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in miceJournal of Clinical Investigation, 2011
- Association of IFN-γ Signal Transduction Defects with Impaired HLA Class I Antigen Processing in Melanoma Cell LinesClinical Cancer Research, 2011
- Identification of E2F1 as an Important Transcription Factor for the Regulation of Tapasin ExpressionJournal of Biological Chemistry, 2010
- Stage-Specific Inhibition of MHC Class I Presentation by the Epstein-Barr Virus BNLF2a Protein during Virus Lytic CyclePLOS Pathogens, 2009
- Epigenetic Enhancement of Antigen Processing and Presentation Promotes Immune Recognition of TumorsCancer Research, 2008
- HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significanceOncogene, 2008
- Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAPPLOS Pathogens, 2008
- Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cellsCancer Immunology, Immunotherapy, 2007
- Epigenetic Control of the Immune Escape Mechanisms in Malignant CarcinomasMolecular and Cellular Biology, 2007
- A Single-nucleotide Deletion Leads to Rapid Degradation ofTAP-1 mRNA in a Melanoma Cell LineJournal of Biological Chemistry, 2003